Primary hyperoxaluria is an inherited disorder that results from the overproduction of endogenous oxalate, leading to recurrent kidney stones, nephrocalcinosis, kidney failure and life-threatening systemic disease. This Consensus Statement from ERKNet and OxalEurope provides recommendations for the management of primary hyperoxaluria, including consideration of conventional therapies, new therapies and recommendations for patient follow-up.
Just published in Nat. Rev. Nephrol. | Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope
Consensus Statement from ERKNet and OxalEurope provides recommendations for the management of primary hyperoxaluria.
Back
Fig.: Glyoxylate metabolism in primary hyperoxaluria. [Groothoff, J.W., Metry, E., Deesker, L. et al. Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope. Nat Rev Nephrol (2023).]